ESMSX | VEURX | ESMSX / VEURX | |
Total Expense Ratio | 1.10 | 0.25 | 440% |
Annual Report Gross Expense Ratio | 1.11 | 0.25 | 444% |
Fund Existence | 8 years | 35 years | - |
Gain YTD | 5.079 | 8.229 | 62% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 156M | 28B | 1% |
Annual Yield % from dividends | 5.17 | 3.01 | 172% |
Returns for 1 year | 1.81 | 5.92 | 31% |
Returns for 3 years | 3.86 | 12.05 | 32% |
Returns for 5 years | 60.83 | 58.61 | 104% |
Returns for 10 years | N/A | 27.68 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HQH | 15.21 | 0.09 | +0.60% |
abrdn Healthcare Investors | |||
NUEM | 28.27 | 0.02 | +0.07% |
Nuveen ESG Emerging Markets Equity ETF | |||
SHUS | 40.62 | N/A | N/A |
Stratified LargeCap Hedged ETF | |||
CVY | 23.39 | -0.02 | -0.09% |
Invesco Zacks Multi-Asset Income ETF | |||
GSLC | 105.69 | -0.30 | -0.28% |
Goldman Sachs ActiveBeta® US LgCp Eq ETF |